SEOM clinical guideline in nasopharynx cancer (2017).
M PastorA Lopez PousaE Del BarcoP Perez SeguraB Gonzalez AstorgaB CasteloT BonfillJ Martinez TruferoJ Jose GrauRicard MesíaPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2017)
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.